Abstract
Background According to the World Health Organization, occupational exposures to hazardous chemicals are estimated to cause over 370,000 premature annual deaths. The risks due to multiple workplace chemical exposures, and those occupations most susceptible to the resulting health effects, remain poorly characterized.
Objectives The aim of this study is to identify occupations with elevated toxicant biomarker concentrations and increased health risk associated with toxicant exposures in a working US population from diverse categories of occupation. More specifically, we aim to 1) define differences in chemical exposures based on occupation description, 2) identify occupational groups with similar chemical exposure profiles, and 3) identify occupational groups with chemical biomarker levels exceeding acceptable health-based biomarker levels.
Methods For this observational study of 51,008 participants, we used data from the 1999-2014 National Health and Nutrition Examination Survey. We characterized differences in chemical exposures by occupational group for 129 chemicals by applying a series of generalized linear models with the outcome as biomarker concentrations and the main predictor as the occupational groups, adjusting for age, sex, race/ethnicity, poverty income ratio, study period, and biomarker of tobacco use. We identified groups of occupations with similar chemical exposure profiles via hierarchical clustering. For each occupational group, we calculated percentages of participants with chemical biomarker levels exceeding acceptable health-based guidelines.
Results Blue collar workers from “Construction”, “Professional, Scientific, Technical Services”, “Real Estate, Rental, Leasing”, “Manufacturing”, and “Wholesale Trade” have higher biomarker levels of toxic chemicals such as several heavy metals, acrylamide, glycideamide, and several volatile organic compounds compared to their white-collar counterparts. For these toxicants, 1-58% of blue-collar workers from these industries have toxicant concentrations exceeding acceptable levels.
Discussion Blue collar workers have toxicant levels higher relative to their white-collar counterparts, often exceeding acceptable levels associated with noncancer effects. Our findings identify multiple occupations to prioritize for targeted interventions and health policies to monitor and reduce high toxicant exposures.
Competing Interest Statement
At the time of the writing of the manuscript, Dr. Patel was a consultant and shareholder of XY.health. Dr. Patel is also paid by J&J. All other authors declare they have nothing to disclose.
Funding Statement
This study was funded by Ravitz Family Foundation, University of Michigan Forbes Institute for Cancer Discovery, Harvard Data Science Initiative, University of Michigan Center for Occupational Health and Safety Engineering, and National Institutes of Health (R01 ES028802, P30 ES017885, P30 CA046592, UG3 CA267907)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The NHANES datasets are openly available and can be obtained from https://www.n.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of Competing Interest At the time of the writing of the manuscript, Dr. Patel was a consultant and shareholder of XY.health. Dr. Patel is also paid by J&J. All other authors declare they have nothing to disclose.
Data Availability
All code and data produced for this manuscript are available online at https://github.com/vynguyen92/nhanes_occupational_exposures. All data produced are available as an interactive app at https://chiragjp.shinyapps.io/nhanes_occupational_exposures/.
https://github.com/vynguyen92/nhanes_occupational_exposures
https://chiragjp.shinyapps.io/nhanes_occupational_exposures/